PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7842649

CMATRIX: software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system.

R Ball·S L Schwartz
View original source ↗Export metadata ↓

Abstract

Physiologically based pharmacokinetic (PBPK) modeling is based on an understanding of the physical and biological factors governing drug distribution. It is a procedure requiring composition of differential equations describing the distribution of drugs among physiologically defined compartments. CMATRIX is a program that facilitates development of PBPK models. In CMATRIX, the model is represented as a matrix of transfer parameters; the program generates a corresponding system of differential equations, and solves them numerically. This system dramatically improves the ease with which PBPK models can be developed, allowing the freedom to construct subcompartments down to the receptor level.

Explore related subjects

Body Fluid CompartmentsComputer SimulationHumansModels, BiologicalPharmacokineticsSoftwareTissue DistributionJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Ball, S L Schwartz. 1994. CMATRIX: software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system.. https://doi.org/10.1016/0010-4825(94)90023-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Bradykinin shifts endothelial fluid passage from para- to transcellular routes.

The signalling peptide bradykinin (BK) is implicated in inflammation and angiogenesis. It promotes fluid transport from blood vessels to interstitial space, and thus facilitates oedema formation. To clarify whether paracellular or transcellular pathways mediate this effect, we investigated the BK-stimulated fluid transport across endothelial monolayers in vitro by comparison of electrical and fluorescence methods. Electrical cell impedance sensing monitored a biphasic response of cell layers to BK with high time resolution: a short decrease (18%, 1 min) was followed by a more sustained increase in paracellular resistance (30%, 10 min). The two phases can be assigned to second messengers of the BK-signalling pathway: Ca(2+) for the decrease and cyclic adenosine monophosphate for the rise of resistance, respectively. Despite tightening of the intercellular clefts, BK increased the fluid permeability by 39%, indicating transcellular fluid transport. Additionally, BK stimulated both in- and outwardly directed membrane trafficking as assessed by vesicular fluid uptake (by 49%) and secretion of von Willebrandt factor (by 85%). In conclusion, the combination of electrical and fluorescence data suggests that BK induces a shift from para- to transcellular fluid transport across endothelium.

Body Fluid Compartments↗
PubMed2006

Beta2-microglobulin, a uremic toxin with a double meaning.

beta(2)M is a strong and independent indicator of hemodialysis patient outcomes and an excellent surrogate for middle molecules, and deserves to be routinely monitored and incorporated into dialysis adequacy targets. beta(2)M has a double meaning, reflecting both dialysis efficacy in terms of solute mass transfer and patient bioactivity. The work of Ward et al. in this issue warrants a study to test the hypothesis that long daily hemodiafiltration treatment would be the optimal renal replacement modality to improve dialysis patient outcomes.

Body Fluid Compartments↗